TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
TuHURA BIOSCIENCES, INC./NV (HURA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 3.04 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 2.52M shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 524.18K shares, a 299.55% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 251.66K shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 11.63K shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 394.49K shares, a 57.82% increase from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 249.96K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.52M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 3.04M shares 10-Q · filed 2026-08-14 | 3.29M shares derived: sum of 3 quarters · filed 2026-08-14 | 3.30M shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 524.18K shares 10-Q · filed 2026-05-15 | 775.84K shares derived: sum of 2 quarters · filed 2026-05-15 | 787.47K shares derived: sum of 3 quarters · filed 2026-05-15 | 787.47K shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 251.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 263.29K shares derived: sum of 2 quarters · filed 2026-03-31 | 263.29K shares derived: sum of 3 quarters · filed 2026-03-31 | 394.49K shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 11.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 11.63K shares derived: sum of 2 quarters · filed 2025-11-14 | 142.82K shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 131.19K shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 131.19K shares 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | 249.96K shares 10-K · filed 2025-03-31 | |||
| 2013-09-30 | -120.00K shares 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |